Clinical Classification of MAFLD Based Liver Biopsy

Not yet recruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

February 8, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2038

Conditions
Metabolic Dysfunction Associated Steatotic Liver DiseaseMetabolic Dysfunction-associated Steatohepatitis (MASH)
Trial Locations (6)

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

Hangzhou Normal University Affiliated Hospital, Hangzhou

Zhongshan Hospital, Fudan University, Shanghai

Unknown

Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

Tianjin Second People's Hospital, Tianjin

All Listed Sponsors
collaborator

Fudan University

OTHER

collaborator

Tianjin Second People's Hospital

OTHER

collaborator

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

The Affiliated Hospital of Hangzhou Normal University

OTHER

collaborator

Ruijin Hospital

OTHER

lead

Beijing Friendship Hospital

OTHER

NCT06795646 - Clinical Classification of MAFLD Based Liver Biopsy | Biotech Hunter | Biotech Hunter